Supra Medical

Company Overview

Snapshot

Founded in October 2022 by Nir Sinai and Adiel Barak, Supra Medical operates with 1-10 employees. The company has completed 2 funding rounds, with Alon MedTech Ventures participating in both. In August 2025, Supra Medical secured its latest funding round.

Business overview

Supra Medical is a medical device startup focused on ophthalmic drug delivery. The company develops an in-office injector for the suprachoroidal space, designed to provide a simple, effective, and safe method for drug administration. This innovative approach enables ophthalmologists to perform suprachoroidal drug administration in-office, facilitating long-lasting treatments for various eye conditions. The technology aims to improve outcomes for a wide range of treatments and supports the development of gene therapies, ultimately enhancing patient vision and quality of life. Supra Medical operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drug Delivery, targeting the North American and European markets.

Company Intelligence Q&A

What is Supra Medical's core product?

Supra Medical's core product is an in-office injector designed for suprachoroidal drug administration, enabling ophthalmologists to deliver treatments for various eye conditions effectively and safely.

When was Supra Medical founded?

Supra Medical was founded in October 2022.

Who are the founders of Supra Medical?

Supra Medical was founded by Nir Sinai and Adiel Barak.

Which investor participated in Supra Medical's funding rounds?

Alon MedTech Ventures participated in Supra Medical's funding rounds in November 2022 and August 2025.

What is the primary sector of Supra Medical?

Supra Medical's primary sector is Health Tech & Life Sciences, specifically focusing on Pharma & Medical Biotechnology and Drug Delivery.